Javad Shahidi - Net Worth and Insider Trading

Javad Shahidi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Javad Shahidi owns 1 companies in total, including Centessa Pharmaceuticals PLC (CNTA) .

Click here to see the complete history of Javad Shahidi’s form 4 insider trades.

Insider Ownership Summary of Javad Shahidi

Ticker	Comapny	Transaction Date	Type of Owner
CNTA	Centessa Pharmaceuticals PLC	2022-03-07	Chief Medical Officer

Javad Shahidi Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Javad Shahidi Ownership Network

Ownership Network List of Javad Shahidi

No Data

Ownership Network Relation of Javad Shahidi

Javad Shahidi Owned Company Details

What does Centessa Pharmaceuticals PLC do?

Who are the key executives at Centessa Pharmaceuticals PLC?

Javad Shahidi is the Chief Medical Officer of Centessa Pharmaceuticals PLC. Other key executives at Centessa Pharmaceuticals PLC include director & Chief Executive Officer Saurabh Saha , Chief Financial Officer Gregory M Weinhoff , and Chief People Officer Karen M. Anderson .

Centessa Pharmaceuticals PLC (CNTA) Insider Trades Summary

Over the past 18 months, Javad Shahidi made no insider transaction in Centessa Pharmaceuticals PLC (CNTA). Other recent insider transactions involving Centessa Pharmaceuticals PLC (CNTA) include a net sale of 285,000 shares made by Saurabh Saha , a net sale of 85,000 shares made by Gregory M Weinhoff , and a net sale of 41,751 shares made by Harris Rotman .

In summary, during the past 3 months, insiders sold 370,000 shares of Centessa Pharmaceuticals PLC (CNTA) in total and bought 0 shares, with a net sale of 370,000 shares. During the past 18 months, 484,211 shares of Centessa Pharmaceuticals PLC (CNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 484,211 shares.

Centessa Pharmaceuticals PLC (CNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Centessa Pharmaceuticals PLC Insider Transactions

No Available Data

Javad Shahidi Mailing Address

Above is the net worth, insider trading, and ownership report for Javad Shahidi. You might contact Javad Shahidi via mailing address: C/o Centessa Pharmaceuticals Plc, 3rd Floor, 1 Ashley Road, Altrincham, Cheshire X0 Wa14 2dt.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.